EPIDEMIOLOGICAL IMPACT AND DISEASE BURDEN OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN EUROPE

被引:1
作者
Ludwig, A. [1 ]
Hengel, H. [1 ]
机构
[1] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany
关键词
PREGNANT-WOMEN; CMV INFECTION; PASSIVE-IMMUNIZATION; GANCICLOVIR THERAPY; PRENATAL-DIAGNOSIS; TOXOPLASMA-GONDII; RISK-FACTORS; HEARING-LOSS; SEROPREVALENCE; TRANSMISSION;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In Europe, congenital cytomegalovirus (CMV) infection is the leading cause of neurological disabilities in children, causing severe sequelae such as sensorineural hearing loss, neurodevelopmental delay or blindness. The infection causes high disease burden and costs. Nevertheless, there is little awareness of CMV among medical officials and the general public. Although the individual risk of congenital CMV infection is greatest from a primary infection of the mother during pregnancy, maternal non-primary infections also account for a substantial disease burden associated with congenital CMV. Screening programmes for pregnant women and newborns are widely discussed, but have not been implemented by any public health authority in Europe so far. This article gives an overview about a variety of European and other relevant studies regarding CMV seroprevalence, congenital CMV infection and disease as well as screening strategies and preventive approaches.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 69 条
[1]   Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation [J].
Acosta, E. P. ;
Brundage, R. C. ;
King, J. R. ;
Sanchez, P. J. ;
Sood, S. ;
Agrawal, V. ;
Homans, J. ;
Jacobs, R. F. ;
Lang, D. ;
Romero, J. R. ;
Griffin, J. ;
Cloud, G. ;
Whitley, R. ;
Kimberlin, D. W. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (06) :867-872
[2]   Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial [J].
Adler, SP ;
Finney, JW ;
Manganello, AM ;
Best, AM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) :240-246
[3]   Cytomegalovirus infections [J].
Adler, Stuart P. ;
Marshall, Beth .
PEDIATRICS IN REVIEW, 2007, 28 (03) :92-100
[4]  
Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969
[5]   Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland [J].
Alanen, A ;
Kahala, K ;
Vahlberg, T ;
Koskela, P ;
Vainionpää, R .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (01) :50-56
[6]   Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee [J].
Arvin, AM ;
Fast, P ;
Myers, M ;
Plotkin, S ;
Rabinovich, R .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :233-239
[7]   Congenital cytomegalovirus infection in a northern Italian region [J].
Barbi, M ;
Binda, S ;
Primache, V ;
Clerici, D .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1998, 14 (08) :791-796
[8]   Diagnosis of congenital CMV infection via dried blood spots [J].
Barbi, Maria ;
Binda, Sandro ;
Caroppo, Simona .
REVIEWS IN MEDICAL VIROLOGY, 2006, 16 (06) :385-392
[9]   Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus [J].
Boppana, SB ;
Fowler, KB ;
Britt, WJ ;
Stagno, S ;
Pass, RF .
PEDIATRICS, 1999, 104 (01) :55-60
[10]   Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. [J].
Boppana, SB ;
Rivera, LB ;
Fowler, KB ;
Mach, M ;
Britt, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1366-1371